In This Article:
- By insider
CEO of Moderna Inc (30-Year Financial, Insider Trades) Stephane Bancel (insider trades) sold 15,775 shares of MRNA on 12/21/2020 at an average price of $140.06 a share. The total sale was $2.2 million.
Moderna Inc has a market cap of $49.81 billion; its shares were traded at around $125.880000 with and P/S ratio of 196.69. GuruFocus has detected 5 severe warning signs with Moderna Inc. .
CEO Recent Trades:
-
CEO Stephane Bancel sold 15,775 shares of MRNA stock on 12/21/2020 at the average price of $140.06. The price of the stock has decreased by 10.12% since.
-
CEO Stephane Bancel sold 19,000 shares of MRNA stock on 12/17/2020 at the average price of $137.77. The price of the stock has decreased by 8.63% since.
-
CEO Stephane Bancel sold 11,046 shares of MRNA stock on 12/11/2020 at the average price of $159.18. The price of the stock has decreased by 20.92% since.
-
CEO Stephane Bancel sold 22,832 shares of MRNA stock on 12/10/2020 at the average price of $158.07. The price of the stock has decreased by 20.36% since.
-
CEO Stephane Bancel sold 21,046 shares of MRNA stock on 12/04/2020 at the average price of $148.11. The price of the stock has decreased by 15.01% since.
Directors and Officers Recent Trades:
-
Chief Medical Officer Tal Zvi Zaks sold 17,129 shares of MRNA stock on 12/21/2020 at the average price of $142.59. The price of the stock has decreased by 11.72% since.
-
President Stephen Hoge sold 20,000 shares of MRNA stock on 12/14/2020 at the average price of $163.63. The price of the stock has decreased by 23.07% since.
-
Chief Medical Officer Tal Zvi Zaks sold 25,034 shares of MRNA stock on 12/14/2020 at the average price of $157.81. The price of the stock has decreased by 20.23% since.
-
Chief Medical Officer Tal Zvi Zaks sold 20,000 shares of MRNA stock on 12/07/2020 at the average price of $158.47. The price of the stock has decreased by 20.57% since.
-
President Stephen Hoge sold 20,000 shares of MRNA stock on 12/03/2020 at the average price of $141.08. The price of the stock has decreased by 10.77% since.
For the complete insider trading history of MRNA, click here
.This article first appeared on GuruFocus.